About the Study

Study Design (Methodology):This will be a multicenter, phase IV, interventional study to assess the efficacy and safety of TARGIN(R)(Oxycodone/Naloxone) in Korean patients who are dissatisfied with their current analgesic medication (WHO step II analgesi

Inclusion Criteria

Exclusion Criteria

Study Team

Team Member

Study Coordinator
Team Member

Site Manager
Team Member

Principal Investigator

Share this study:           

Places where you can participate

Location Status
Research at MD Anderson
1515 Holcombe Blvd., TX
USA
Enrolling Connect to Clinical Site
Clinical Research Center - Nevada
3218, 1012 E Sahara Ave,, NV
USA
Enrolling Connect to Clinical Site
Clinical Research Center of Florida
550 SW 3rd Street, Suite #305, FL
USA
Enrolling Connect to Clinical Site